For the first time, the U.S. Food and Drug Administration (FDA) has approved a biologic medication for the treatment of pediatric plaque psoriasis.
On Nov. 4, 2016, the FDA approved Enbrel (etanercept) for the treatment of chronic moderate to severe plaque psoriasis in children ages 4 to 17.
One of the earliest biologics on the market, Enbrel has been approved for the treatment of psoriasis in adults since 2004. It is an injectable medication that works by lowering the activity of a protein known as tumor necrosis factor-alpha.
The protein, called a cytokine, is released by the immune system to trigger inflammation.
Even though Enbrel is new to pediatric psoriasis, it’s been used for more than a decade to treat children with juvenile idiopathic arthritis, according to Enbrel’s website.
It has also been investigated as potential medication for pediatric psoriasis for several years.
A study published in February 2016 in the Journal of the American Academy of Dermatology tested the long-term effects of Enbrel as a treatment for children with psoriasis. According to the results of the study, which involved almost 70 children ranging in age from 4 to 17, Enbrel stayed safe and effective for up to five years.
The most common adverse events experienced by children in the study included headache, upper respiratory tract infection and the common cold, as reported in the study.
Enbrel is manufactured by Amgen.
For more information on Enbrel, or other treatments for pediatric psoriasis, visit NPF’s Patient Navigation Center.
Driving discovery, creating community
For more than 50 years, we’ve been driving efforts to cure psoriatic disease and improve the lives of those affected. But there’s still plenty to do! Learn how you can help our advocacy team shape the laws and policies that affect people with psoriasis and psoriatic arthritis – in your state and across the country. Help us raise funds to support research by joining Team NPF, where you can walk, run, cycle, play bingo or create your own fundraising event. If you or someone you love needs free, personalized support for living a healthier life with psoriatic disease, contact our Patient Navigation Center. And keep the National Psoriasis Foundation going strong by making a donation today. Together, we will find a cure.